• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性水化以预防对比剂肾病:小题大做?

Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing?

机构信息

Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, USA.

Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, USA.

出版信息

Kidney Int. 2017 Jul;92(1):4-6. doi: 10.1016/j.kint.2017.04.005. Epub 2017 May 18.

DOI:10.1016/j.kint.2017.04.005
PMID:28528129
Abstract

Clinical guidelines recommend prophylactic hydration to reduce the risk of contrast-induced nephropathy in high-risk patients, including those with chronic kidney disease. A recent single-center randomized trial showed no significant difference in the incidence of contrast-induced nephropathy in ambulatory patients with stage 3 chronic kidney disease who were randomized to no prophylactic hydration versus normal saline hydration. While these results may identify patients who are less likely to benefit from prophylactic hydration, nephrologists and interventionalists should carefully consider the generalizability of these results to individual patients.

摘要

临床指南建议对高危患者(包括慢性肾脏病患者)进行预防性水化,以降低对比剂肾病的风险。最近的一项单中心随机试验显示,在随机分为无预防性水化与生理盐水水化的 3 期慢性肾脏病门诊患者中,对比剂肾病的发生率无显著差异。虽然这些结果可能确定了那些不太可能从预防性水化中获益的患者,但肾病学家和介入放射学家应仔细考虑这些结果对个体患者的可推广性。

相似文献

1
Prophylactic hydration to prevent contrast-induced nephropathy: much ado about nothing?预防性水化以预防对比剂肾病:小题大做?
Kidney Int. 2017 Jul;92(1):4-6. doi: 10.1016/j.kint.2017.04.005. Epub 2017 May 18.
2
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.预防性水化以保护高危对比剂肾病(AMACING)患者的肾功能免受血管内碘造影剂影响:一项前瞻性、随机、3 期、对照、开放标签、非劣效性试验。
Lancet. 2017 Apr 1;389(10076):1312-1322. doi: 10.1016/S0140-6736(17)30057-0. Epub 2017 Feb 21.
3
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography.碳酸氢钠水化 1 小时与慢性肾脏病患者静脉注射对比增强计算机断层扫描中标准围手术期生理盐水水化的随机比较。
Nephrol Dial Transplant. 2014 May;29(5):1029-36. doi: 10.1093/ndt/gfu025. Epub 2014 Feb 27.
4
The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.在慢性肾脏病患者中,血管紧张素受体阻滞剂与钙通道阻滞剂联合应用对造影剂肾病没有益处。
Ren Fail. 2013;35(4):434-9. doi: 10.3109/0886022X.2013.766566. Epub 2013 Feb 18.
5
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.一项关于生理盐水水化预防慢性肾衰竭患者造影剂肾病的随机试验。
Nephrol Dial Transplant. 2006 Aug;21(8):2120-6. doi: 10.1093/ndt/gfl133. Epub 2006 Apr 12.
6
Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.碳酸氢钠、N-乙酰半胱氨酸和生理盐水预防造影剂肾病。冠状动脉手术患者中三种预防造影剂肾病方案的比较。一项单中心前瞻性对照试验。
Am Heart J. 2007 Sep;154(3):539-44. doi: 10.1016/j.ahj.2007.05.012.
7
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.碳酸氢钠预防对比剂肾病:一项随机对照试验。
JAMA. 2004 May 19;291(19):2328-34. doi: 10.1001/jama.291.19.2328.
8
Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.使用甘露醇和呋塞米进行强制等容利尿以预防接受冠状动脉造影的慢性肾脏病患者发生造影剂肾病:一项随机对照试验。
Am J Kidney Dis. 2009 Oct;54(4):602-9. doi: 10.1053/j.ajkd.2009.03.024. Epub 2009 Jun 17.
9
Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.碳酸氢钠治疗预防对比剂肾病:一项系统评价和荟萃分析。
Am J Kidney Dis. 2009 Apr;53(4):617-27. doi: 10.1053/j.ajkd.2008.08.033. Epub 2008 Nov 22.
10
Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.中心静脉压指导下的液体管理对慢性肾脏病和充血性心力衰竭患者对比剂肾病的预防作用。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):89-96. doi: 10.1016/j.jcin.2015.09.026. Epub 2015 Dec 9.

引用本文的文献

1
Biomarkers in Contrast-Induced Nephropathy: Advances in Early Detection, Risk Assessment, and Prevention Strategies.造影剂肾病中的生物标志物:早期检测、风险评估及预防策略的进展
Int J Mol Sci. 2025 Mar 21;26(7):2869. doi: 10.3390/ijms26072869.
2
Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions.慢性完全闭塞病变经皮治疗中对比剂肾病的评估
Interv Med Appl Sci. 2019 Jun;11(2):95-100. doi: 10.1556/1646.11.2019.15.
3
Adenosine antagonists for prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials with trial sequential analysis.
用于预防造影剂肾病的腺苷拮抗剂:一项采用序贯试验分析的随机对照试验的荟萃分析
Exp Ther Med. 2019 Jul;18(1):85-98. doi: 10.3892/etm.2019.7566. Epub 2019 May 9.
4
Prophylactic Intravenous Hydration to Protect Renal Function From Intravascular Iodinated Contrast Material (AMACING): Long-term Results of a Prospective, Randomised, Controlled Trial.预防性静脉补液以保护肾功能免受血管内碘化造影剂影响(AMACING):一项前瞻性、随机、对照试验的长期结果
EClinicalMedicine. 2018 Nov 9;4-5:109-116. doi: 10.1016/j.eclinm.2018.10.007. eCollection 2018 Oct-Nov.